DXA-defined sarcopenia

1 paper1 finding

Humans1

Upstream

1

Procollagen type III N-terminal propeptide

no changein humans1

1 study

Procollagen type III N-terminal propeptide has no effect on DXA-defined sarcopenia in humans.
“was not independently associated with DXA-defined sarcopenia (odds ratio per 1-standard deviation, p > 0.05).”
Humanstype 2 diabetes mellitus; adjusted clinical modelfemalesn = 99
Evaluating procollagen type III N-terminal propeptide (P3NP) as a biomarker of sarcopenia in women with type 2 diabetes: a cross-sectional study
Archives of endocrinology and metabolism15 Oct 2026

More on Procollagen type III N-terminal propeptide

Latest

1 in 12 months

Archives of Endocrinology and MetabolismYesterday

Evaluating procollagen type III N-terminal propeptide (P3NP) as a biomarker of sarcopenia in women with type 2 diabetes: a cross-sectional study

Cross-sectional study of 99 peopleSarcopenia